Qube Research & Technologies (QRT)
ELV icon

Qube Research & Technologies (QRT)’s Elevance Health ELV Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$33M Buy
+112,717
New +$37M 0.04% 610
2025
Q2 		– Sell
-42,576
Closed -$17.1M – 3642
2025
Q1 		$18.5M Sell
42,576
-437,207
-91% -$176M 0.02% 786
2024
Q4 		$177M Buy
479,783
+281,322
+142% +$118M 0.23% 89
2024
Q3 		$103M Buy
198,461
+143,632
+262% +$76.7M 0.15% 148
2024
Q2 		$29.7M Sell
54,829
-382,772
-87% -$202M 0.05% 461
2024
Q1 		$227M Buy
437,601
+85,122
+24% +$42.3M 0.36% 46
2023
Q4 		$166M Sell
352,479
-139,025
-28% -$64.3M 0.32% 62
2023
Q3 		$214M Buy
491,504
+182,889
+59% +$83M 0.56% 25
2023
Q2 		$137M Buy
+308,615
New +$142M 0.5% 31
2023
Q1 		– Sell
-67,299
Closed -$34.5M – 2666
2022
Q4 		$34.5M Sell
67,299
-31,954
-32% -$16.2M 0.18% 138
2022
Q3 		$45.1M Buy
99,253
+54,194
+120% +$25.9M 0.27% 81
2022
Q2 		$21.7M Buy
45,059
+43,551
+2,888% +$21.5M 0.16% 160
2022
Q1 		$741K Sell
1,508
-1,738
-54% -$794K 0.01% 1328
2021
Q4 		$1.5M Buy
+3,246
New +$1.37M 0.01% 964
2021
Q3 		– Sell
-25,326
Closed -$9.67M – 2348
2021
Q2 		$9.67M Buy
25,326
+7,594
+43% +$2.9M 0.11% 215
2021
Q1 		$6.37M Sell
17,732
-19,227
-52% -$6.18M 0.1% 249
2020
Q4 		$11.9M Buy
+36,959
New +$11.3M 0.17% 121
2020
Q3 		– Sell
-51,277
Closed -$13.5M – 1781
2020
Q2 		$13.5M Buy
+51,277
New +$13.7M 0.2% 117
2020
Q1 		– Sell
-5,666
Closed -$1.71M – 1257
2019
Q4 		$1.71M Buy
5,666
+4,057
+252% +$1.12M 0.05% 402
2019
Q3 		$386K Buy
+1,609
New +$441K 0.26% 117
2019
Q2 		– Sell
-11,552
Closed -$3.31M – 447
2019
Q1 		$3.31M Buy
11,552
+8,494
+278% +$2.46M 0.44% 55
2018
Q4 		$803K Buy
3,058
+1,100
+56% +$302K 0.35% 59
2018
Q3 		$537K Buy
1,958
+264
+16% +$68.5K 0.07% 208
2018
Q2 		$403K Sell
1,694
-633
-27% -$147K 0.25% 82
2018
Q1 		$511K Buy
+2,327
New +$547K 0.2% 71

Other funds holding ELV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

Qube Research & Technologies (QRT)'s ELV Position: Q1 2026 in Review

Qube Research & Technologies (QRT) opened a new position in Elevance Health (ELV) in Q1 2026: 112,717 shares worth $33M. The stake represents 0.04% of the portfolio and ranks #610 among its holdings. This is a return to the name: Qube Research & Technologies (QRT) previously reported a position in ELV as recently as Q1 2025.

Qube Research & Technologies (QRT) first reported a position in ELV in Q1 2018 and has held it in 25 quarters since. The position peaked at $227M in Q1 2024. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

  • Qube Research & Technologies (QRT) held 112,717 shares of Elevance Health worth $33M as of Q1 2026.
  • Elevance Health was a new Qube Research & Technologies (QRT) position in Q1 2026.
  • Elevance Health made up 0.04% of Qube Research & Technologies (QRT)'s portfolio in Q1 2026, its #610 holding.
  • Qube Research & Technologies (QRT) first reported a position in Elevance Health in Q1 2018 and has held it in 25 quarters since.
  • Qube Research & Technologies (QRT)'s Elevance Health position peaked at $227M in Q1 2024.
  • 1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q1 2026, filed 15 May 2026.